Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 259.85
+8.85 (3.53%)
At close: Jul 27, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 113.41 billion as of July 27, 2026. Its market cap has increased by 161.03% in one year.
Market Cap
113.41B
Enterprise Value
117.75B
Revenue
34.20B
Ranking
n/a
PE Ratio
64.80
Stock Price
259.85
ChartMarket Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 113.41B, an increase of 32,513.92%. That is a compound annual growth rate of 30.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 113.41B | 25.05% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 250.45B |
| Granules India | 206.58B |
| AstraZeneca Pharma India | 200.00B |
| Caplin Point Laboratories | 187.34B |
| Jubilant Pharmova | 152.38B |
| CORONA Remedies | 129.23B |
| Procter & Gamble Health | 111.61B |
| Sanofi India | 78.02B |